⌘K

Login Start Free

Home/Filings/4/0000914062-13-000142

4//SEC Filing

MAULDIN JOHN F 4

Accession 0000914062-13-000142

CIK 0001133416other

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 5:30 PM ET

Size

5.2 KB

Accession

0000914062-13-000142

Insider Transaction Report

Form 4

Period: 2013-03-28

GALECTIN THERAPEUTICS INCGALT

Director

Transactions

Award
Stock Option (right to buy)
2013-03-28+16,714→ 16,714 total
Exercise: $3.59Exp: 2023-03-28→ Common Stock (16,714 underlying)

Footnotes (1)

[F1]The option vests quarterly in eight equal installments beginning on May 12, 2013.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

GALECTIN THERAPEUTICS INC

CIK 0001133416

Entity typeother

Related Parties

1

filerCIK 0001522480

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 5:30 PM ET
Size: 5.2 KB

View on SEC.gov